RGCC Ltd . is a leading company in analysis  of circulating tumor cells

as well  as  Cancer Stem Cells.

Through their analysis, is able to offer services  in  clinical field as well 

as in R&D  in  pharmaceutical  industry.

By   using   the   most   advanced  and

innovative  technologies of molecular

and    cellular    biology,   RGCC   Ltd.

manages     to    overpass      several

restrictions  and  difficulties   that the 

analysis of   CTCs  (Circulating  Tumor

Cells)  and   CSCs  (Circulating   Stem  

Cells) involves.

Hence, through  such  an  approach a massive  amount   of  informationand data  has   been  generated  in order  to be used for identifying

new «drugable» targets  as  well  as  offering methods in  clinical  

practice like new and precise  assays, risk scale and classification of  

cancer  patients.